Onderneming XSPY PHAR Nasdaq Stockholm
Aandelen
SE0009973563
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Per Andersson
CEO | Chief Executive Officer | 57 | 01-09-06 |
Director of Finance/CFO | 52 | 08/02 | |
Thomas Walz
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-22 |
Chief Tech/Sci/R&D Officer | 60 | 01-01-18 | |
Investor Relations Contact | 63 | 15-05-19 | |
Sales & Marketing | - | 15-03-22 | |
Andreas Konar
PRN | Corporate Officer/Principal | 75 | 01-01-10 |
Edward Jordan
PRN | Corporate Officer/Principal | 55 | 15-09-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 71 | 01-01-15 | |
Carl-Johan Spak
BRD | Director/Board Member | 68 | 01-01-15 |
Chairman | 70 | 19-05-22 | |
Director/Board Member | 55 | 01-01-17 | |
Christine Lind
BRD | Director/Board Member | 50 | 01-01-19 |
Director/Board Member | 66 | 01-01-21 | |
Robert Molander
BRD | Director/Board Member | 59 | 19-05-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 31 253 542 | 18 510 319 ( 59,23 %) | 0 | 59,23 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 118 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. |